Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-18-287503
Filing Date
2018-09-28
Accepted
2018-09-28 16:31:03
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d620452d10ka.htm 10-K/A 24210
2 EX-31.1 d620452dex311.htm EX-31.1 10973
3 EX-31.2 d620452dex312.htm EX-31.2 10953
  Complete submission text file 0001193125-18-287503.txt   47293
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-31791 | Film No.: 181094531
SIC: 2834 Pharmaceutical Preparations